Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors Arnulf Langhammer, Siri Forsmo, Unni Syversen

Published Date September 2009 Volume 2009:4 Pages 365—380

DOI http://dx.doi.org/10.2147/COPD.S4797

Published 30 September 2009

Arnulf Langhammer1, Siri Forsmo2, Unni Syversen3,4

1HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology (NTNU), Verdal, Norway; 2Department of Public Health and General Practice, NTNU, Trondheim, Norway; 3Department of Cancer Research and Molecular Medicine, NTNU, Trondheim, Norway; 4Department of Endocrinology, St. Olav’s University Hospital, Trondheim, Norway

Abstract: Patients with COPD have high risk for osteoporosis and fractures. Hip and vertebral fractures might impair mobility, and vertebral fractures further reduce lung function. This review discusses the evidence of bone loss due to medical treatment opposed to disease severity and risk factors for COPD, and therapeutic options for the prevention and treatment of osteoporosis in these patients. A review of the English-language literature was conducted using the MEDLINE database until June 2009. Currently used bronchodilators probably lack adverse effect on bone. Oral corticosteroids (OCS) increase bone resorption and decrease bone formation in a dose response relationship, but the fracture risk is increased more than reflected by bone densitometry. Inhaled corticosteroids (ICS) have been associated with both increased bone loss and fracture risk. This might be a result of confounding by disease severity, but high doses of ICS have similar effects as equipotent doses of OCS. The life-style factors should be modified, use of regular OCS avoided and use of ICS restricted to those with evidenced effect and probably kept at moderate doses. The health care should actively reveal risk factors, include bone densitometry in fracture risk evaluation, and give adequate prevention and treatment for osteoporosis.

Keywords: COPD, corticosteroids, bronchodilators, bone mineral density, osteoporosis, fractures

General overview

Licence for Fig 2 is uploaded

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease

Geiger-Brown J, Lindberg S, Krachman S, McEvoy CE, Criner GJ, Connett JE, Albert RK, Scharf SM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:389-397

Published Date: 20 February 2015

Sleep quality predicts quality of life in chronic obstructive pulmonary disease

Steven M Scharf, Nimrod Maimon, Tzahit Simon-Tuval, et al

International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:1-12

Published Date: 22 December 2010

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

Neeta Thakur, Paul D Blanc, Laura J Julian, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:263-269

Published Date: 10 August 2010

Treating postmenopausal osteoporosis in women at increased risk of fracture – critical appraisal of bazedoxifene: a review

Peter Vestergaard, Susanna vid Streym Thomsen

International Journal of Women's Health 2009, 1:97-103

Published Date: 17 August 2009

Exacerbation rate, health status and mortality in COPD – a review of potential interventions

Terence AR Seemungal, John R Hurst, Jadwiga A Wedzicha

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:203-223

Published Date: 29 May 2009

Markers of early disease and prognosis in COPD

Morten Dahl, Børge G Nordestgaard

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:157-167

Published Date: 7 April 2009

Pulmonary hypertension associated with COPD

Jean Elwing, Ralph J Panos

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:55-70

Published Date: 18 March 2008

Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients

Steven Kesten, Richard Casaburi, David Kukafka, Christopher B Cooper

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:127-136

Published Date: 18 March 2008